Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus
about
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsWest Nile Virus: biology, transmission, and human infectionViral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flavivirusesIsolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile VirusPathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral EvasionCrystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface EpitopesAntibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinPreparation and immunogenic properties of a recombinant West Nile subunit vaccineDefining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster ModelComplex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.Induction of Epitope-Specific Neutralizing Antibodies against West Nile VirusIdentification of Novel Small-Molecule Inhibitors of West Nile Virus InfectionType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesGenetically delivered antibody protects against West Nile virusThe relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virusThe structural immunology of antibody protection against West Nile virusThe Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionUsing high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infectionWest Nile Virus Attenuates Activation of Primary Human MacrophagesStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentDefining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and miceHuman Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment StepProgress on the development of therapeutics against West Nile virusComplement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile VirusThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Viral Vaccines and CTL ResponseStructure of the St. Louis Encephalitis Virus Postfusion Envelope TrimerEpidemiological and clinical aspects on West Nile virus, a globally emerging pathogen.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal modelsYeast surface display for protein engineering and characterizationHuman Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in VivoIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.Systems immunology reveals markers of susceptibility to West Nile virus infection.Generating Recombinant Antibodies against Putative Biomarkers of Retinal InjuryAberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds.Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody
P2860
Q24289014-E5A5E5B0-E684-4EDC-B88D-06150C211712Q26865618-901DC769-59CB-4EA0-8B5F-1B06C06E4AB4Q27333686-81948F65-A501-4777-AE8F-DA4BB934A55AQ27473288-2A08E94C-8F13-49B3-8588-C8D2586D79E4Q27477543-346C716F-792B-453C-BAB2-23910E125364Q27477610-689E7CAD-FD53-49A5-B31B-85153C7EC088Q27477718-6896FB9E-0D2F-4D68-B261-7C50289B21D4Q27478202-9B3BA6DA-49FF-422B-8931-B52E8CE2FBA6Q27480795-3EBA7BE2-320A-4E2C-9248-C2756A5419D9Q27481420-BDD4E429-9D65-4F67-9CE7-C9A790A14F7BQ27484980-6927AF63-26F4-4A48-B305-8F7FDC9D4544Q27484983-757EC8D2-1ABA-4DCA-97AB-AAED51152DB4Q27485031-F23EAEAF-23F2-41C9-8110-34A1BFCCB8F9Q27485481-06FAA188-B4B9-4ECC-8546-EC3079A3554AQ27486421-6853187F-458D-430C-B6D1-BD06DE56831EQ27487955-9BDB5509-894B-488C-82A0-512430F974ADQ27488224-D15CC06E-77CD-454E-B485-929C547E95A6Q27488247-F5862037-4282-431D-B374-EFCAABEDA2CFQ27488297-78745B91-1DB9-4E96-8C5C-E80D23FDF6DEQ27488364-AD71BE37-C14D-43DC-8500-621ED7804E73Q27488750-8F33ADB2-B60D-4157-8409-A1754AB9063EQ27488791-0C29C1A3-1C49-4C8D-88AF-89E17E91ECBFQ27489893-0939A93F-B30F-44B6-8546-01903AE96FD7Q27490423-9EA5D603-4B21-4464-B144-46CC1269F98FQ27491317-278614CA-2F2B-402E-8898-BA312AAECB99Q27491330-40FC06B1-59ED-489E-9134-6B15FC349F3AQ27674868-85D12354-7998-420A-9D26-417126FE1ED1Q30250251-F7866E04-0500-455B-B9FA-81E581E3399CQ30252022-783DAFF2-5C37-46E5-99C4-81EA023FA3FAQ33293219-DEB85E97-5ECF-4640-A919-F9A92FFE1CCFQ33299124-D5A7D20B-25B7-46FA-AD27-98BEB65A8D73Q33588683-9B5B89B6-04E8-469F-A330-0C9A38936993Q33627189-9DE10197-55FA-4120-A30F-26728530239EQ33802834-111543B5-0E03-44E4-8A71-561BC35EB00CQ34226542-AA0262E2-55CB-41F9-85D3-95A570CDECEAQ34261496-52B0D5B3-47D6-4165-AF53-21555E8B553BQ34784962-9C4CC6A5-F19A-4023-9585-6E326C75F858Q35527001-23E05ADF-5169-4D7E-91D3-B4111C85493AQ35611679-C28D6106-1097-4BC5-8B16-A3D57C31A57FQ35854520-7098A9BB-1406-4182-BF4E-7BB3D6360E8F
P2860
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Protective and Therapeutic Cap ...... oteins against West Nile Virus
@nl
Protective and therapeutic cap ...... oteins against West Nile virus
@ast
Protective and therapeutic cap ...... oteins against West Nile virus
@en
type
label
Protective and Therapeutic Cap ...... oteins against West Nile Virus
@nl
Protective and therapeutic cap ...... oteins against West Nile virus
@ast
Protective and therapeutic cap ...... oteins against West Nile virus
@en
prefLabel
Protective and Therapeutic Cap ...... oteins against West Nile Virus
@nl
Protective and therapeutic cap ...... oteins against West Nile virus
@ast
Protective and therapeutic cap ...... oteins against West Nile virus
@en
P2093
P2860
P50
P1433
P1476
Protective and therapeutic cap ...... oteins against West Nile virus
@en
P2093
Akikazu Murakami
Cassandra Lambeth
Harald Foellmer
Jianhua Sui
John F Anderson
Kalipada Kar
Kristin Noonan
L Hannah Gould
Raymond A Koski
Wayne A Marasco
P2860
P304
14606-14613
P356
10.1128/JVI.79.23.14606-14613.2005
P577
2005-12-01T00:00:00Z